Skip to main content.
Menu

Lamictal

Picture of R. Jan Gurley

A new start-up is mining the FDA's adverse event data for medications and finding potentially dangerous patterns that the regulatory agency hasn't addressed — but should.

CONNECT WITH THE COMMUNITY